U.S. Physical Therapy, Inc. (USPH): Price and Financial Metrics
U.S. Physical Therapy, Inc. (USPH)
Today's Latest Price: $100.62 USD
Updated Feb 28 2:21pm
Add USPH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 66 in Medical - Services
See all "A" rated Strong Buy stocks
USPH Stock Summary
- Price to trailing twelve month operating cash flow for USPH is currently 23.66, higher than 80.4% of US stocks with positive operating cash flow.
- Of note is the ratio of U S Physical Therapy Inc's sales and general administrative expense to its total operating expenses; 86.42% of US stocks have a lower such ratio.
- With a year-over-year growth in debt of 136.55%, U S Physical Therapy Inc's debt growth rate surpasses 89.25% of about US stocks.
- If you're looking for stocks that are quantitatively similar to U S Physical Therapy Inc, a group of peers worth examining would be USLM, WHD, MGPI, SGA, and KE.
- Visit USPH's SEC page to see the company's official filings. To visit the company's web site, go to www.usph.com.
USPH Stock Price Chart More Charts
USPH Price/Volume Stats
| Current price | $100.62 | 52-week high | $148.48 |
| Prev. close | $104.19 | 52-week low | $98.53 |
| Day low | $98.53 | Volume | 64,409 |
| Day high | $103.32 | Avg. volume | 83,242 |
| 50-day MA | $118.81 | Dividend yield | 1.15% |
| 200-day MA | $124.23 | Market Cap | 1.29B |
U.S. Physical Therapy, Inc. (USPH) Company Bio
U.S. Physical Therapy operates clinics which provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. The company was founded in 1990 and is based in Houston, Texas.
USPH Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $100.62 | $49.03 | -61% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for U S Physical Therapy Inc. To summarize, we found that U S Physical Therapy Inc ranked in the 27th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 61.17%. In terms of the factors that were most noteworthy in this DCF analysis for USPH, they are:
- Interest coverage, a measure of earnings relative to interest payments, is 30.88 -- which is good for besting 87.24% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
- The business' balance sheet reveals debt to be 8% of the company's capital (with equity being the remaining amount). Approximately only 21.54% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- USPH's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 47.05% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -62% |
| 1% | -62% |
| 2% | -61% |
| 3% | -61% |
| 4% | -61% |
| 5% | -60% |
Want more companies with a valuation profile/forecast similar to that of U S Physical Therapy Inc? See MTD, COO, BIO, VREX, and WAT.
Top Stories View All
The Correct Mindset to Have After the Stock Market Plummets
Cannabis Stocks: The Week in Review
Best & Worst Performing Stock Industries for February 27, 2020
Best & Worst Performing Small Cap Stocks for February 27, 2020
Best & Worst Performing Mid Cap Stocks for February 27, 2020
View All Top Stories
Loading social stream, please wait...